|
1
|
Hongo M, Nagasaki Y and Shoji T:
Epidemiology of esophageal cancer: Orient to occident. Effects of
chronology, geography and ethnicity. J Gastroenterol Hepatol.
24:729–735. 2009.
|
|
2
|
Wheeler JB and Reed CE: Epidemiology of
esophageal cancer. Surg Clin North Am. 92:1077–1087. 2012.
|
|
3
|
Bollschweiler E, Wolfgarten E, Gutschow C
and Hölscher AH: Demographic variations in the rising incidence of
esophageal adenocarcinoma in white males. Cancer. 92:549–555.
2001.
|
|
4
|
Reid BJ, Li X, Galipeau PC and Vaughan TL:
Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new
synthesis. Nat Rev Cancer. 10:87–101. 2010.
|
|
5
|
Engel LS, Chow WH, Vaughan TL, et al:
Population attributable risks of esophageal and gastric cancers. J
Natl Cancer Inst. 95:1404–1413. 2003.
|
|
6
|
Lagergren J, Bergström R, Lindgren A and
Nyrén O: Symptomatic gastroesophageal reflux as a risk factor for
esophageal adenocarcinoma. N Engl J Med. 340:825–831. 1999.
|
|
7
|
Jankowski JA, Harrison RF, Perry I,
Balkwill F and Tselepis C: Barrett’s metaplasia. Lancet.
356:2079–2085. 2000.
|
|
8
|
Miwa K, Segawa M, Takano Y, et al:
Induction of oesophageal and forestomach carcinomas in rats by
reflux of duodenal contents. Br J Cancer. 70:185–189. 1994.
|
|
9
|
Miwa K, Sahara H, Segawa M, et al: Reflux
of duodenal or gastro-duodenal contents induces esophageal
carcinoma in rats. Int J Cancer. 67:269–274. 1996.
|
|
10
|
Miyashita T, Ohta T, Fujimura T, et al:
Duodenal juice stimulates oesophageal stem cells to induce
Barrett’s oesophagus and oesophageal adenocarcinoma in rats. Oncol
Rep. 15:1469–1475. 2006.
|
|
11
|
Miyashita T, Miwa K, Fujimura T, et al:
The severity of duodeno-esophageal reflux influences the
development of different histological types of esophageal cancer in
a rat model. Int J Cancer. 132:1496–1504. 2013.
|
|
12
|
Bonde P, Sui G, Dhara S, et al:
Cytogenetic characterization and gene expression profiling in the
rat reflux-induced esophageal tumor model. J Thorac Cardiovasc
Surg. 133:763–769. 2007.
|
|
13
|
Nawa A, Nishimori K, Lin P, et al: Tumor
metastasis-associated human MTA1 gene: its deduced protein
sequence, localization, and association with breast cancer cell
proliferation using antisense phosphorothioate oligonucleotides. J
Cell Biochem. 79:202–212. 2000.
|
|
14
|
Toh Y, Ohga T, Endo K, et al: Expression
of the metastasis-associated MTA1 protein and its relationship to
deacetylation of the histone H4 in esophageal squamous cell
carcinomas. Int J Cancer. 110:362–367. 2004.
|
|
15
|
Toh Y, Pencil SD and Nicolson GL: Analysis
of the complete sequence of the novel metastasis-associated
candidate gene, mta1, differentially expressed in mammary
adenocarcinoma and breast cancer cell lines. Gene. 159:97–104.
1995.
|
|
16
|
Iguchi H, Imura G, Toh Y and Ogata Y:
Expression of MTA1, a metastasis-associated gene with histone
deacetylase activity in pancreatic cancer. Int J Oncol.
16:1211–1214. 2000.
|
|
17
|
Higashijima J, Kurita N, Miyatani T, et
al: Expression of histone deacetylase 1 and metastasis-associated
protein 1 as prognostic factors in colon cancer. Oncol Rep.
26:343–348. 2011.
|
|
18
|
Nicolson GL, Nawa A, Toh Y, Taniguchi S,
Nishimori K and Moustafa A: Tumor metastasis-associated human MTA1
gene and its MTA1 protein product: role in epithelial cancer cell
invasion, proliferation and nuclear regulation. Clin Exp
Metastasis. 20:19–24. 2003.
|
|
19
|
Moon WS, Chang K and Tarnawski AS:
Overexpression of metastatic tumor antigen 1 in hepatocellular
carcinoma: Relationship to vascular invasion and estrogen
receptor-alpha. Hum Pathol. 35:424–429. 2004.
|
|
20
|
Kai L, Samuel SK and Levenson AS:
Resveratrol enhances p53 acetylation and apoptosis in prostate
cancer by inhibiting MTA1/NuRD complex. Int J Cancer.
126:1538–1548. 2010.
|
|
21
|
Toh Y, Yamamoto M, Endo K, et al: Histone
H4 acetylation and histone deacetylase 1 expression in esophageal
squamous cell carcinoma. Oncol Rep. 10:333–338. 2003.
|
|
22
|
Sun WJ, Zhou X, Zheng JH, et al: Histone
acetyltransferases and deacetylases: molecular and clinical
implications to gastrointestinal carcinogenesis. Acta Biochim
Biophys Sin (Shanghai). 44:80–91. 2012.
|
|
23
|
Toh Y and Nicolson G: MTA1 of the MTA
(metastasis-associated) gene family and its encoded proteins:
molecular and regulatory functions and role in human cancer
progression. Atlas Genet Cytogenet Oncol Haematol. 15:303–315.
2011.
|
|
24
|
Moon HE, Cheon H and Lee MS:
Metastasis-associated protein 1 inhibits p53-induced apoptosis.
Oncol Rep. 18:1311–1314. 2007.
|
|
25
|
Abdel-Latif MM, Duggan S, Reynolds JV and
Kelleher D: Inflammation and esophageal carcinogenesis. Curr Opin
Pharmacol. 9:396–404. 2009.
|
|
26
|
Ramsey MR, He L, Forster N, Ory B and
Ellisen LW: Physical association of HDAC1 and HDAC2 with p63
mediates transcriptional repression and tumor maintenance in
squamous cell carcinoma. Cancer Res. 71:4373–4379. 2011.
|
|
27
|
Langer R, Mutze K, Becker K, et al:
Expression of class I histone deacetylases (HDAC1 and HDAC2) in
oesophageal adenocarcinomas: an immunohistochemical study. J Clin
Pathol. 63:994–998. 2010.
|
|
28
|
Toh Y, Kuwano H, Mori M, Nicolson GL and
Sugimachi K: Overexpression of metastasis-associated MTA1 mRNA in
invasive oesophageal carcinomas. Br J Cancer. 79:1723–1726.
1999.
|
|
29
|
Tong JK, Hassig CA, Schnitzler GR,
Kingston RE and Schreiber SL: Chromatin deacetylation by an
ATP-dependent nucleosome remodelling complex. Nature. 395:917–921.
1998.
|
|
30
|
Xue Y, Wong J, Moreno GT, Young MK, Côté J
and Wang W: NURD, a novel complex with both ATP-dependent
chromatin-remodeling and histone deacetylase activities. Mol Cell.
2:851–861. 1998.
|
|
31
|
Wade PA, Gegonne A, Jones PL, Ballestar E,
Aubry F and Wolffe AP: Mi-2 complex couples DNA methylation to
chromatin remodelling and histone deacetylation. Nat Genet.
23:62–66. 1999.
|
|
32
|
Zhang Y, Ng HH, Erdjument-Bromage H,
Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits
reveals a histone deacetylase core complex and a connection with
DNA methylation. Genes Dev. 13:1924–1935. 1999.
|
|
33
|
Bowen NJ, Fujita N, Kajita M and Wade PA:
Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys
Acta. 1677:52–57. 2004.
|
|
34
|
Toh Y, Kuninaka S, Endo K, et al:
Molecular analysis of a candidate metastasis-associated gene, MTA1:
possible interaction with histone deacetylase 1. J Exp Clin Cancer
Res. 19:105–111. 2000.
|
|
35
|
Kumar R, Wang RA and Bagheri-Yarmand R:
Emerging roles of MTA family members in human cancers. Semin Oncol.
30(Suppl 16): S30–S37. 2003.
|
|
36
|
Manavathi B, Peng S, Rayala SK, et al:
Repression of Six3 by a corepressor regulates rhodopsin expression.
Proc Natl Acad Sci USA. 104:13128–13133. 2007.
|
|
37
|
Toh Y and Nicolson GL: The role of the MTA
family and their encoded proteins in human cancers: molecular
functions and clinical implications. Clin Exp Metastasis.
26:215–227. 2009.
|
|
38
|
Luo J, Su F, Chen D, Shiloh A and Gu W:
Deacetylation of p53 modulates its effect on cell growth and
apoptosis. Nature. 408:377–381. 2000.
|
|
39
|
Li DQ, Ohshiro K, Reddy SD, et al: E3
ubiquitin ligase COP1 regulates the stability and functions of
MTA1. Proc Natl Acad Sci USA. 106:17493–17498. 2009.
|
|
40
|
Miyatani T, Kurita N, Mikami C, et al:
Malignant potential of Barrett’s esophagus: special reference to
HDAC-1 and MTA-1 expression. Hepatogastroenterology. 58:472–476.
2011.
|
|
41
|
Yoo YG, Na TY, Seo HW, et al: Hepatitis B
virus X protein induces the expression of MTA1 and HDAC1, which
enhances hypoxia signaling in hepatocellular carcinoma cells.
Oncogene. 27:3405–3413. 2008.
|
|
42
|
Hofer MD, Kuefer R, Varambally S, et al:
The role of metastasis-associated protein 1 in prostate cancer
progression. Cancer Res. 64:825–829. 2004.
|
|
43
|
Taddei A, Roche D, Bickmore WA and
Almouzni G: The effects of histone deacetylase inhibitors on
heterochromatin: implications for anticancer therapy? EMBO Rep.
6:520–524. 2005.
|
